Search results
Billionaire Ken Griffin Is Buying These Dividend Stocks Hand Over Fist. Should You?
Motley Fool via Yahoo Finance· 3 minutes agoDespite this solid rebound, Bank of America appears to be attractively valued. Its shares trade at a...
Merck’s MilliporeSigma agrees to acquire Mirus Bio for $600m
Pharmaceutical Technology via Yahoo Finance· 21 hours agoMerck KGaA’s Life Science business in the US and Canada, MilliporeSigma, has entered a definitive...
Merck KGaA to buy gene therapy tools maker for $600M
BioPharma Dive via Yahoo Finance· 22 hours agoDive Brief: German drugmaker Merck KGaA agreed to buy Mirus Bio for $600 million to build expertise in a critical part of viral vector-based gene therapy...
Here's Why Merck (MRK) Stock Has Outperformed Industry YTD
Zacks via Yahoo Finance· 4 days agoMerck MRK boasts more than six blockbuster drugs in its portfolio, with PD-L1 inhibitor Keytruda...
McKesson, Merck back Atropos Health’s $33M round to accelerate drug development with AI
VentureBeat· 12 hours agoAtropos Health, a healthcare technology company focused on generating personalized real-world...
Merck & Co Inc (MRK) Sits And Waits For Direction At $131.30 Price – Stocks Register
Stocks Register· 1 day agoMerck & Co Inc (NYSE:MRK) at last check was buoying at $131.30 on Thursday, May 23 with a rise of 0.15% from its closing price on previous day. Taking a look at stock we notice ...
Merck KGaA Buys Mirus Bio for $600 Million
Market Watch· 1 day agoBy Ian Walker Germany's Merck KGaA is buying life-science company Mirus Bio for $600 million as it expands its life science business sector. The...
MRK Stock Sees Decline of Approximately
Knox Daily· 1 day agoThe buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Merck & Co Inc shares valued at $492,135,715 ...
Merck & Co., Inc. (NYSE:MRK) is a favorite amongst institutional investors who own 79%
Simply Wall St. via Yahoo Finance· 2 days agoKey Insights Institutions' substantial holdings in Merck implies that they have significant...
Insiders At Merck Sold US$12m In Stock, Alluding To Potential Weakness
Simply Wall St. via Yahoo Finance· 6 days agoThe fact that multiple Merck & Co., Inc. (NYSE:MRK) insiders offloaded a considerable amount of...
